Companies House · 00284385

ELI LILLY AND COMPANY LIMITED

UK registered company, private limited company, incorporated 5 Feb 1934.

Active
50
Public contracts
2
Spend payments
£76.8k
Total spend

ELI LILLY AND COMPANY LIMITED is a UK company registered at Companies House under number 00284385. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
00284385
Status
Active
Company type
Private Limited Company
Incorporated
5 Feb 1934
Country of origin
United Kingdom
Registered office
ELI LILLY AND COMPANY LIMITED, LILLY HOUSE, BASINGSTOKE, HAMPSHIRE, RG21 4FA, UNITED KINGDOM
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to ELI LILLY AND COMPANY LIMITED.

ProcurementBuyerAwardedValue
NHS Framework, North of England, Branded Medicines - Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024NHS England
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024NHS England
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
CA02825 Ixekizumab (Taltz®)The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Biologic and Biosimilar MedicineseTenderwales
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Biosimilars and Biologics with Associated Medicines Homecare ServicesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
Proprietary DrugseTenderwales
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines - National TenderNHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS England
TeriparatideThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Ixekizumab (Taltz®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood MedicineThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Proprietary DrugsVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
Invitation to offer for NHS London Branded Medicines - Tranche A and AnnualNHS England
Invitation to offer for NHS London Branded Medicines - Tranche A and AnnualNHS England
NHS South of England Branded Medicines - Tranche B and AnnualNHS England
NHS South of England Branded Medicines - Tranche B and AnnualNHS England
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS South of England Branded Medicines - Tranche A - September 2023NHS England
NHS Framework, North of England, Branded Medicines - Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS Branded Medicines Tranche Framework for London and South of EnglandNHS England21 Jul 2024£381m
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England4 Apr 2024£1bn
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS South of England Branded Medicines - Tranche A - September 2023NHS England17 Jul 2023£249.8m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS Framework Agreement-Branded Medicines - National Proprietary PharmaceuticalsNHS England23 Apr 2023£304.5m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework for North of England Branded Medicines Tranche A & Annual TrancheNHS England8 Feb 2023£262m
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework Agreement for London, Branded Medicines - Tranche A and AnnualNHS England14 Jul 2022£153.8m

Supplier identities

How this company appears as a supplier across the data.

Recent transparency payments

2 payments recorded, totalling £76,800.

PayerDescriptionDateAmount
united-lincolnshire-hospitals-nhs-trustPHARMACY27 Mar 2014£38.4k
united-lincolnshire-hospitals-nhs-trustPHARMACY3 Oct 2013£38.4k

FAQs about ELI LILLY AND COMPANY LIMITED

Is ELI LILLY AND COMPANY LIMITED an active company?

ELI LILLY AND COMPANY LIMITED (company number 00284385) is recorded as "Active", incorporated on 5 Feb 1934.

What does ELI LILLY AND COMPANY LIMITED do?

Its Companies House nature-of-business (SIC) is: 21100 - Manufacture of basic pharmaceutical products.

Has ELI LILLY AND COMPANY LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

How much public money has ELI LILLY AND COMPANY LIMITED received?

2 transparency-spend payments totalling £76,800 are recorded against ELI LILLY AND COMPANY LIMITED.

Where is ELI LILLY AND COMPANY LIMITED based?

Its registered office is ELI LILLY AND COMPANY LIMITED, LILLY HOUSE, BASINGSTOKE, HAMPSHIRE, RG21 4FA, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable